EMORY University Collaboration Announcement
PhorMed Inc (“PhorMed” or the “Company”) has entered into an agreement with Atlanta-based academic research leader Emory University for assistance in developing the Company’s proprietary drug for Parkinson’s disease.
“Emory’s experts, with their extensive knowledge in Parkinson’s disease, will be a great addition to the PhorMed team and we look forward to a long and successful collaboration” said Dr. McCoy Moretz, the Chief Executive Officer of the company.
About Emory University:
LAST UPDATED: JANUARY 29, 2020
Founded in 1836, Emory University is a national center for teaching, research, and service, awarding more than 4,921 undergraduate and graduate degrees annually. It is recognized by U.S. News & World Report as one of the top 25 universities in the US (ranked 21st in the 2019 report). In 1966 the University’s Board of Trustees integrated all of Emory’s health components into the Robert W. Woodruff Health Sciences Center. The Woodruff Health Sciences Center joins those components of Emory University concerned with patient care, education of health professionals, research affecting health and illness, and policies for prevention and treatment of disease. Its components include schools of medicine, nursing, and public health; Yerkes National Primate Research Center; Winship Cancer Institute; Emory Global Health Institute, and Emory Healthcare, the most comprehensive health system in Georgia.
Funded Research at Emory
Researchers at Emory University received $734 million from external funding agencies in fiscal year 2018, marking a 17 percent increase over the previous year, with such funding having increased more than 50 percent over the past 10 years. Federal agencies awarded $440.8 million, or more than 60 percent of the total, led by the National Institutes of Health, with $359.2 million in awards. NIH funding represented nearly 82 percent of total federal dollars awarded to Emory.
See second article in http://whsc.emory.edu/publications/hs-update-archive/11-2018.html